Patents by Inventor Mei-Feng Hong

Mei-Feng Hong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110223267
    Abstract: The present invention provides compositions of bakuchiol (UP246) having low levels of impurities, particularly furanocoumarin impurities. The present invention further provides improved methods for the isolation, purification and analysis of compositions of bakuchiol. Finally, the present invention provides methods for using the purified bakuchiol compositions and formulations thereof for the prevention and treatment of various diseases and conditions mediated by cyclooxygenase (COX), lipoxygenase (LOX), minor inflammatory conditions and various microbial infections. The methods of this invention are comprised of administering to a host in need thereof an effective amount of the composition of this invention together with a pharmaceutically acceptable carrier.
    Type: Application
    Filed: March 16, 2011
    Publication date: September 15, 2011
    Applicant: Unigen, Inc.
    Inventors: Qi Jia, Mei-Feng Hong
  • Publication number: 20060251749
    Abstract: The present invention provides compositions of bakuchiol (UP246) having low levels of impurities, particularly furanocoumarin impurities. The present invention further provides improved methods for the isolation, purification and analysis of compositions of bakuchiol. Finally, the present invention provides methods for using the purified bakuchiol compositions and formulations thereof for the prevention and treatment of various diseases and conditions mediated by cyclooxygenase (COX), lipoxygenase (LOX), minor inflammatory conditions and various microbial infections. The methods of this invention are comprised of administering to a host in need thereof an effective amount of the composition of this invention together with a pharmaceutically acceptable carrier.
    Type: Application
    Filed: May 9, 2006
    Publication date: November 9, 2006
    Applicant: Unigen Pharmaceuticals, Inc.
    Inventors: Qi Jia, Mei-Feng Hong
  • Publication number: 20030113797
    Abstract: The present invention relates generally to a technology platform, referred to as Phytologix™ for the discovery of novel bioactive pharmaceutical, nutraceutical and cosmetic agents. Specifically, this invention includes an integrated system for the collection of medicinal plants and creation of informatic databases related to these plants. This invention also relates to an improved standardized extraction and fractionation process, which provides significant advantages over the prior art in the terms of simplicity, efficiency of the separations, the quality of the library, low cost of the process and extraordinary throughput. This invention provides details to the structure dereplication process by utilizing the technology such as HPLC/PDA/MS coupled with high throughput bioassay data and an internal pure compound library. It has been proven to be much more efficient and accurate when compared to the prior art methods.
    Type: Application
    Filed: June 27, 2002
    Publication date: June 19, 2003
    Applicant: UNIGEN PHARMACEUTICALS, INC.
    Inventors: Qi Jia, Mei-Feng Hong
  • Publication number: 20020064883
    Abstract: The present invention provides an improved method for using the measurement of total urinary 17 KS-S, referred to herein as the urinary Anabolic/Catabolic Index (ACI), as part of a biomarker for biological age.
    Type: Application
    Filed: December 4, 2001
    Publication date: May 30, 2002
    Inventors: Qi Jia, Mei-Feng Hong, Stephen Cherniske
  • Patent number: 6326209
    Abstract: The present invention provides an improved method for using the measurement of total urinary 17 KS-S, referred to herein as the urinary Anabolic/Catabolic Index (ACI), as part of a biomarker for biological age.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: December 4, 2001
    Assignee: Univera Pharmaceuticals, Inc.
    Inventors: Qi Jia, Mei-Feng Hong, Stephen Cherniske